Company Active LTD

Company profile

Fleet Bioprocessing Limited

Custom Bioconjugation | Immunoassay Development Company | Fleet Bioprocessing

Fleet Bioprocessing are a Immunoassay Development Company based in Hampshire. We offer Contract R&D and Manufacturing Services, with Unrivalled Expertise in Immunoassay Development, and Bioconjugation. Call Now on +44 (0) 1252 614477

CRN
04035456
Founded
2000
Age
25

Overview

Legal name
FLEET BIOPROCESSING LIMITED
Region
Unknown
Registered address
ASTON HOUSE
CORNWALL AVENUE
LONDON
N3 1LF
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

5 events
31 Jan
2027

Accounts due

Accounts Due

Next accounts due date

23 Jul
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

09 Jul
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Apr
2025

Accounts filed

Accounts

Last accounts made up date

18 Jul
2000

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2007
Funded years
2007, 2019
Age at first award
6 years

Projects

2019 Collaborative R&D Lead participant

Rapid and Inexpensive Characterisation of Immunoassay Conjugates (RIChIC)

1 Sep 2019 to 30 Nov 2020

Awarded
£35,000
Total cost £50,000

Fleet Bioprocessing Ltd. are experts in the development of immunoassays, widely-used tests for the diagnosis of diseases which rely on the well-known specificity of antibodies to detect specific molecules. Examples in common use include tests for detecting HIV and hepatitis, for diagnosing thyroid hormone abnormalities, or for differentiating heart attack...

2019 Collaborative R&D Lead participant

Faster and Cheaper Techniques for the Characterisation of Immunoassay Conjugates

1 Jan 2019 to 31 Mar 2019

Awarded
£10,000
Total cost £10,000

"**Fleet Bioprocessing Ltd.** are expert in the development of **immunoassays,** highly sensitive and specific antibody-based _in vitro_ diagnostic procedures widely used in the diagnosis of disease states. Immunoassay performance is critically dependent on **labelled antibody and antigen conjugates** which enable **immobilisation** or **detection** of th...

2007 Collaborative R&D

Marine Microbes - A Powerful new source of bioactive healthcare compounds

1 Mar 2007 to 28 Feb 2011

Awarded
£43,714
Total cost £87,426

Awaiting Public Summary

Product types

Collaborative R&D